Recent News

Latest GeoVax News

  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
450
Comments on HHS Initiative “Ending the HIV Epidemic: A Plan for America” ATLANTA, GA, February 14, 2019 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company...
Last modified on Continue reading
125
NBAAD Logo
 Bringing Attention to Minority Health Disparities in HIV/AIDS and the Need for a Vaccine ATLANTA, GA, February 7, 2019 – GeoVax Labs, Inc. (OTCQB: GOVX)....
Last modified on Continue reading
580
Applauding HIV Elimination Goals and Encouraging More Resources Toward Vaccine Development ATLANTA, GA, February 6, 2019 – GeoVax Labs, Inc. (OTCQB: GOVX). During Tuesday night’s State...
Last modified on Continue reading
268
GeoVax Zika Vaccine Provides Potential for 100% Protection & Reduced Side-Effect Risks ATLANTA, GA, January 24, 2019 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company...
Last modified on Continue reading
620
Company continues to advance novel vaccines to prevent infectious threats ATLANTA, GA, January 22, 2019 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human...
Last modified on Continue reading